BORIS and FATE co-expression is a prognostic indicator in patients with epithelial ovarian cancer

被引:0
|
作者
Singhal, P. [1 ]
Villella, J. [2 ]
Andrews, C. [3 ]
Lele, S. [1 ]
Odunsi, K. [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
[3] SUNY Buffalo, Buffalo, NY 14260 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
195
引用
收藏
页码:S87 / S87
页数:1
相关论文
共 50 条
  • [21] Identification of co-expression modules associated with platinum resistance in ovarian cancer patients using WGCNA
    Riedl, Markus
    Seborova, Karolina
    Hlavac, Viktor
    Hruda, Martin
    Rob, Lukas
    Bouda, Jiri
    Spacek, Jiri
    Sedlakova, Iva
    Soucek, Pavel
    Mohr, Thomas
    Vaclavikova, Radka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 570 - 571
  • [22] Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients
    Li, Yong
    Sun, Zhenqing
    Liu, Kewei
    Qiu, Wensheng
    Yao, Ruyong
    Feng, Tongtong
    Xin, Chao
    Yue, Lu
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1055 - 1061
  • [23] Gene co-expression network analysis of two ovarian cancer datasets
    Hong, Shengjun
    Dong, Hua
    Jin, Li
    Xiong, Momiao
    2010 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE WORKSHOPS (BIBMW), 2010, : 269 - 274
  • [24] Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
    Berger, Karoline
    Rhost, Sara
    Rafnsdottir, Svanheidur
    Hughes, Eamon
    Magnusson, Ylva
    Ekholm, Maria
    Stal, Olle
    Ryden, Lisa
    Landberg, Goran
    BMC CANCER, 2021, 21 (01)
  • [25] Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
    Karoline Berger
    Sara Rhost
    Svanheiður Rafnsdóttir
    Éamon Hughes
    Ylva Magnusson
    Maria Ekholm
    Olle Stål
    Lisa Rydén
    Göran Landberg
    BMC Cancer, 21
  • [26] High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
    He, Yao
    Wang, Hui
    Yan, Meina
    Yang, Xinxin
    Shen, Rong
    Ni, Xiaoge
    Chen, Xiaokun
    Yang, Peifang
    Chen, Miao
    Lu, Xiaodong
    Shao, Genbao
    Zhou, Xiaoming
    Shao, Qixiang
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5327 - 5336
  • [27] Prognostic value of preoperative hyponatremia in patients with epithelial ovarian cancer
    Guo, Jing-Yi
    Gong, Ting-Ting
    Yang, Zhuo
    Liu, Yi
    Wang, Ling
    Wang, Ya-Nan
    Wu, Qi-Jun
    JOURNAL OF CANCER, 2019, 10 (04): : 836 - 842
  • [28] Application of the immunoscore as prognostic biomarkers in patients with epithelial ovarian cancer
    Lee, Shin-Wha
    Jung, Hee Jung
    Lee, Young-Jae
    Lee, Ha-Young
    Kim, Yong-Man
    Kim, Young-Tak
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [29] Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
    Jonna Berntsson
    Sebastian Lundgren
    Björn Nodin
    Mathias Uhlén
    Alexander Gaber
    Karin Jirström
    Journal of Ovarian Research, 7
  • [30] Expression and prognostic value of CLIC1 in epithelial ovarian cancer
    Yu, Wentao
    Cui, Ran
    Qu, Hong
    Liu, Chongdong
    Deng, Haiteng
    Zhang, Zhenyu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (06) : 4943 - 4949